The Lingwood laboratory studies B cell antibody responses to both HIV and influenza with the goal of:

  1. Understanding how antigenic sites of vulnerability are initially perceived by specific germline B cell receptor (BCR) sequences
  2. How that recognition process can direct antibody affinity maturation toward production of broadly neutralizing anti-viral responses.